30 September 2017 Amount % Income Statement Revenue from sales 169.4 100.0% Gross profit 54.7 32.3% Earnings before interest and tax (625.5) -369.2% Net Profit (Loss) (646.6) -381.6% Balance Sheet
transformation via the Olympus program, leading to $350M run-rate savings by 2023 Asset full potential with strong revenue and margin growth across PET, IOD and Fibers through commercial excellence Adjacency
committed to: Cost transformation via the Olympus program, leading to $350M run-rate savings by 2023 Asset full potential with strong revenue and margin growth across PET, IOD and Fibers through
total loans 3.8% 3.9% 3.5% (0.1)% 0.3% Ratio of loan loss reserves to NPL 159.3% 160.2% 160.0% (0.9)% (0.7)% Total capital adequacy ratio 17.97% 18.17% 18.26% (0.20)% (0.29)% ** Less deferred revenue Bank
to submit our management’s discussion and analysis for the fiscal year ended December 31, 2019, as follows: For the year ended December 31 Change 2019 2018 MB MB % Sales revenue 371.33 316.83 17.20
., which is demonstrated as the above transactions, is proper and gives benefits to the company which can increase revenue and profits to the group companies. Please be acknowledge for your information Yours
clarification of the performance of the Company and its subsidiaries as follows: Performance in the Quarter Ending June 30, 2017 (Quarter 2) Revenue from Sales and Services The Company and its subsidiaries
commercial banks’ main sources of revenue – posted a slight increase from the previous quarter and the same period of last year. Despite several commercial banks’ reductions in lending rates during this
total loans 3.8% 3.7% 3.2% 0.1% 0.6% Ratio of loan loss reserves to NPLs 154.0% 151.2% 173.6% 2.8% (19.6)% Total capital adequacy ratio 18.73% 18.13% 18.32% 0.60% 0.41% ** Less deferred revenue Bangkok